Grb2 Is Required for the Development of Neointima in Response to Vascular Injury

Objective—Neointima formation occurs in arteries in response to mechanical or chemical injury and is responsible for substantial morbidity. In this work, the role of the intracellular linker protein Grb2 in the pathogenesis of neointima formation was examined. Grb2 is a critical signaling protein that facilitates the activation of the small GTPase ras by receptor tyrosine kinases. Methods and Results—Cultured rat aortic smooth muscle cells were treated with an antisense morpholino to Grb2 and these cells showed a reduced proliferative response to platelet-derived growth factor stimulation. Grb2−/− mice do not survive embryonic development. Grb2+/− mice appear normal at birth and are fertile but have defective signaling in several tissues. Cultured smooth muscle cells derived from Grb2+/− mice grew at a much slower rate than cells derived from Grb2+/+ mice. Grb2+/− and Grb2+/+ mice were subjected to carotid injury. After 21 days, Grb2+/+ mice developed robust neointima formation that, in some cases, resulted in an occlusive lesion. In contrast, Grb2+/− mice were resistant to the development of neointima Conclusions—Grb2 is an essential component of the signaling cascade resulting in neointima formation after arterial injury.

[1]  E. Buchdunger,et al.  Selective Tyrosine Kinase Inhibitor for the Platelet-Derived Growth Factor Receptor In Vitro Inhibits Smooth Muscle Cell Proliferation After Reinjury of Arterial Intima In Vivo , 1999, Cardiovascular Drugs and Therapy.

[2]  Attila Kovacs,et al.  The role of the Grb2-p38 MAPK signaling pathway in cardiac hypertrophy and fibrosis. , 2003, The Journal of clinical investigation.

[3]  J. Niebauer,et al.  Fighting restenosis after coronary angioplasty: contemporary and future treatment options. , 2002, International journal of cardiology.

[4]  D. Witte,et al.  Distinction in Genetic Determinants for Injury-Induced Neointimal Hyperplasia and Diet-Induced Atherosclerosis in Inbred Mice , 2002, Arteriosclerosis, thrombosis, and vascular biology.

[5]  J. Heasman.  Morpholino oligos: making sense of antisense? , 2002, Developmental biology.

[6]  Levon M Khachigian,et al.  Coronary In-stent Restenosis: Current Status and Future Strategies , 2022 .

[7]  S. Pyne,et al.  Short-Term Local Delivery of an Inhibitor of Ras Farnesyltransferase Prevents Neointima Formation In Vivo After Porcine Coronary Balloon Angioplasty , 2001, Circulation.

[8]  C. Lin,et al.  Inhibition of neointimal formation in porcine coronary artery by a Ras mutant. , 2001, The Journal of surgical research.

[9]  T. Pawson,et al.  Disruption of T cell signaling networks and development by Grb2 haploid insufficiency , 2001, Nature Immunology.

[10]  S. Chien,et al.  Effects of active and negative mutants of Ras on rat arterial neointima formation. , 2000, The Journal of surgical research.

[11]  C. Rogers,et al.  The comparative pathobiology of atherosclerosis and restenosis. , 2000, The American journal of cardiology.

[12]  S. Sartore,et al.  Specific cellular features of atheroma associated with development of neointima after carotid endarterectomy: the carotid atherosclerosis and restenosis study. , 2000, Circulation.

[13]  Anthony J. Muslin,et al.  14‐3‐3 proteins block apoptosis and differentially regulate MAPK cascades , 2000, The EMBO journal.

[14]  M. Sakaguchi,et al.  Manumycin A, inhibitor of ras farnesyltransferase, inhibits proliferation and migration of rat vascular smooth muscle cells. , 1999, Biochemical and biophysical research communications.

[15]  G. Feng,et al.  Gab2, a New Pleckstrin Homology Domain-containing Adapter Protein, Acts to Uncouple Signaling from ERK Kinase to Elk-1* , 1999, The Journal of Biological Chemistry.

[16]  Tony Pawson,et al.  Mammalian Grb2 Regulates Multiple Steps in Embryonic Development and Malignant Transformation , 1998, Cell.

[17]  Qingbo Xu,et al.  Activation of PDGF receptor α in vascular smooth muscle cells by mechanical stress , 1998 .

[18]  G. Wick,et al.  Activation of PDGF receptor alpha in vascular smooth muscle cells by mechanical stress. , 1998, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[19]  A. Wong,et al.  Grb2-associated binder-1 mediates phosphatidylinositol 3-kinase activation and the promotion of cell survival by nerve growth factor. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[20]  J. Summerton,et al.  Morpholino antisense oligomers: design, preparation, and properties. , 1997, Antisense & nucleic acid drug development.

[21]  A. Takeshita,et al.  Adenovirus-mediated transfer of a dominant-negative H-ras suppresses neointimal formation in balloon-injured arteries in vivo. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[22]  W. Birchmeier,et al.  Interaction between Gab1 and the c-Met receptor tyrosine kinase is responsible for epithelial morphogenesis , 1996, Nature.

[23]  A. Godwin,et al.  A Grb2-associated docking protein in EGF- and insulin-receptor signalling , 1996, Nature.

[24]  L. Horwitz,et al.  Multiple growth factors are released from mechanically injured vascular smooth muscle cells. , 1995, The American journal of physiology.

[25]  G. Condorelli,et al.  Inhibition of cellular ras prevents smooth muscle cell proliferation after vascular injury in vivo , 1995, Nature Medicine.

[26]  C. Benjamin,et al.  Convergence of Angiotensin II and Platelet-derived Growth Factor Receptor Signaling Cascades in Vascular Smooth Muscle Cells (*) , 1995, The Journal of Biological Chemistry.

[27]  T. Hunter,et al.  Integrin-mediated signal transduction linked to Ras pathway by GRB2 binding to focal adhesion kinase , 1994, Nature.

[28]  C. Benjamin,et al.  Platelet-derived growth factor stimulates growth factor receptor binding protein-2 association with Shc in vascular smooth muscle cells. , 1994, The Journal of biological chemistry.

[29]  J Downward,et al.  The GRB2/Sem‐5 adaptor protein , 1994, FEBS letters.

[30]  M. Reidy,et al.  Mouse model of arterial injury. , 1993, Circulation research.

[31]  J. Wilcox,et al.  Molecular biology: insight into the causes and prevention of restenosis after arterial intervention. , 1993, The American journal of cardiology.

[32]  A. Ullrich,et al.  The SH2 and SH3 domain-containing protein GRB2 links receptor tyrosine kinases to ras signaling , 1992, Cell.

[33]  J. Downward.  Regulatory mechanisms for ras proteins , 1992, BioEssays : news and reviews in molecular, cellular and developmental biology.

[34]  J. Downward.  Regulation of p21ras by GTPase activating proteins and guanine nucleotide exchange proteins. , 1992, Current opinion in genetics & development.

[35]  M. Reidy,et al.  Inhibition of neointimal smooth muscle accumulation after angioplasty by an antibody to PDGF , 1991, Science.

[36]  M. Reidy,et al.  Proliferation of smooth muscle cells after vascular injury is inhibited by an antibody against basic fibroblast growth factor. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[37]  R. Ross,et al.  Locally acting growth factors for vascular smooth muscle cells: endogenous synthesis and release from platelets. , 1985, Circulation.